The SoPD blog has just posted an article covering the two nilotinib phase II trials (i.e. Georgetown Uni. and MJFF et al.). The article includes a lot of background information, plus links to papers/articles containing further information.
Phase II Trials of Nilotinib for PD: a go... - Cure Parkinson's
Phase II Trials of Nilotinib for PD: a good overview/background article on the SoPD blog
Written by
jeffreyn
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Thank you for sharing.
Not what you're looking for?
You may also like...
SoPD blog post from Simon on the recent results from the NADPARK trial of nicotinamide riboside (Niagen)
condition.\\"
https://scienceofparkinsons.com/2022/03/11/nad-2/
The much larger NOPARK trial is not...
Encouraging results from the CureParkinsons supported Phase II clinical trial of the GLP-1R agonist Liraglutide
GLP-1R data pile
https://cureparkinsons.org.uk/2022/04/liraglutide-trial-results/...
Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD
therapy for PD, warranting further investigation in larger trials.
https://twitter.com/chtzoulis/st
Houston Research Organization Successfully Treats 24 Patients in FDA-Authorized Parkinson’s Study
quantities over repeat treatments.
https://www.hopebio.org/Article?N=000301
Potential disease-modifying therapy enters Phase 2
review of the data of the 101 trial, the drug advanced to the Phase II 201 trial (NCT05424276)....
Related Posts
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases 2022 (TUDCA)
Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease (Nov 20, 2020) 
TUDCA VS. UDCA : Cure Parkinson's UDCA trial ending 2021- Can we give CuATSM a try without waiting for the Australian trial completion (5 years from now)
- Trials Tracking Table with Grouping
